Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

norgestimate and ethinyl estradiol

×

Overview

What is Femynor?

Femynor™ (norgestimate and ethinyl estradiol tablets, USP)

 is a combination oral contraceptive containing the progestational compound norgestimate and the estrogenic compound ethinyl estradiol. Norgestimate is designated as (18,19-Dinor-17-pregn-4-en-20-yn-3-one,17-(acetyloxy)-13-ethyl-, oxime,(17α)-(+)-) and ethinyl estradiol is designated as (19-nor-17α-pregna,1,3,5(10)-trien-20-yne-3,17-diol).



What does Femynor look like?



What are the available doses of Femynor?

Femynor consists of 28 round, biconvex, film-coated tablets in the following order ():

What should I talk to my health care provider before I take Femynor?

Nursing mothers: Not recommended; can decrease milk production. ()

How should I use Femynor?

Femynor Tablets are indicated for use by females of reproductive potential to prevent pregnancy [].

Femynor is dispensed in a blister pack []. Femynor may be started using either a Day 1 start or a Sunday start (see Table 1). For the first cycle of a Sunday Start regimen, an additional method of contraception should be used until after the first 7 consecutive days of administration.


What interacts with Femynor?

Sorry No Records found


What are the warnings of Femynor?

Sorry No Records found


What are the precautions of Femynor?

Sorry No Records found


What are the side effects of Femynor?

Sorry No records found


What should I look out for while using Femynor?

Do not prescribe Femynor to women who are known to have the following conditions:

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke [].


What might happen if I take too much Femynor?

There have been no reports of serious ill effects from overdosage of oral contraceptives, including ingestion by children. Overdosage may cause withdrawal bleeding in females and nausea.


How should I store and handle Femynor?

​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016​Naproxen Tablets, USP: ‘I’‘G’‘340’Naproxen Tablets, USP: ‘IG’‘341’​Naproxen Tablets, USP: ‘I’‘G’‘342’Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature].Dispense in tight, light-resistant containers.*All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc.Rev: 06/2016